Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.4940 EUR
−254.83 M EUR
52.66 M EUR
93.63 M
About CureVac N.V.
Sector
Industry
CEO
Alexander Zehnder
Website
Headquarters
Tübingen
Founded
2020
ISIN
NL0015436031
FIGI
BBG00WMMD7B4
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 5CV is 2.8280 EUR — it has decreased by −5.78% in the past 24 hours. Watch CUREVAC N.V. O.N. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange CUREVAC N.V. O.N. stocks are traded under the ticker 5CV.
5CV stock has fallen by −10.46% compared to the previous week, the month change is a 15.32% rise, over the last year CUREVAC N.V. O.N. has showed a −24.28% decrease.
We've gathered analysts' opinions on CUREVAC N.V. O.N. future price: according to them, 5CV price has a max estimate of 15.11 EUR and a min estimate of 2.36 EUR. Watch 5CV chart and read a more detailed CUREVAC N.V. O.N. stock forecast: see what analysts think of CUREVAC N.V. O.N. and suggest that you do with its stocks.
5CV stock is 6.13% volatile and has beta coefficient of 1.21. Track CUREVAC N.V. O.N. stock price on the chart and check out the list of the most volatile stocks — is CUREVAC N.V. O.N. there?
Today CUREVAC N.V. O.N. has the market capitalization of 647.34 M, it has decreased by −9.62% over the last week.
Yes, you can track CUREVAC N.V. O.N. financials in yearly and quarterly reports right on TradingView.
CUREVAC N.V. O.N. is going to release the next earnings report on Apr 23, 2025. Keep track of upcoming events with our Earnings Calendar.
5CV earnings for the last quarter are 1.51 EUR per share, whereas the estimation was 1.41 EUR resulting in a 7.09% surprise. The estimated earnings for the next quarter are −0.21 EUR per share. See more details about CUREVAC N.V. O.N. earnings.
CUREVAC N.V. O.N. revenue for the last quarter amounts to 493.90 M EUR, despite the estimated figure of 3.35 M EUR. In the next quarter, revenue is expected to reach 6.50 M EUR.
5CV net income for the last quarter is 333.53 M EUR, while the quarter before that showed −72.91 M EUR of net income which accounts for 557.45% change. Track more CUREVAC N.V. O.N. financial stats to get the full picture.
No, 5CV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 20, 2024, the company has 1.17 K employees. See our rating of the largest employees — is CUREVAC N.V. O.N. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CUREVAC N.V. O.N. EBITDA is 185.29 M EUR, and current EBITDA margin is −473.93%. See more stats in CUREVAC N.V. O.N. financial statements.
Like other stocks, 5CV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CUREVAC N.V. O.N. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CUREVAC N.V. O.N. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CUREVAC N.V. O.N. stock shows the sell signal. See more of CUREVAC N.V. O.N. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.